Amid a shortage, drug prices increase at roughly twice their usual rate, suggesting that pharma companies may be exploiting drug shortages to increase profits, according to a new study published in the Annals of Internal Medicine.
A new report from the New England Journal of Medicine-Catalysts about trends in payer-provider integration suggests that the industry is warming up to single-payer — with 61 percent of hospital leaders saying single-payer would boost the industry’s efforts to lower costs and provide better care.
Drugmakers increased the price of 60 products August — a sharp decline from July, which saw 110 price increases, according to a Wells Fargo drug-pricing report.
BlueCross BlueShield of Tennessee will stop covering the prescription opioid OxyContin beginning January 1, 2019.
Consumers continue to embrace digital health tools, with 90% of respondents in a new Rock Health survey using at least one last year, up from 80% in 2016.
Millennials, generation Xers, baby boomers and seniors vary in how they're using virtual care, according to a Deloitte report.
CMS issued a proposed rule Aug. 9 that would make sweeping changes to the Medicare Shared Savings Program, including overhauling the way ACOs share in risks and rewards.
Patients who stay in private rooms as opposed to double occupancy rooms have a reduced risk of central line infections, a hospital-acquired infection that causes thousands of deaths each year, a study published in PLOS ONE found.
Maryland did not adequately follow federal requirements to secure its Medicaid data and information systems, according to an HHS Office of Inspector General report.
Physician burnout increased from 45.5 percent to 54.4 percent between 2011 and 2014, according to an article in the American Journal of Medicine.